covid 19 News and Research

RSS

Evaluating mental health of adults with neurodevelopmental disorders during COVID-19 pandemic

Researchers investigated the impact of the COVID-19 pandemic on anxiety, depression, and mental well-being of adults with neurodevelopmental disorders in the United Kingdom.

12 May 2022

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Researchers performed an unbiased evaluation of the early memory B cell repertoire specific for the Omicron and Delta variants of SARS-CoV-2.

12 May 2022

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

The International Vaccine Institute (IVI) and SK bioscience announced today that SK bioscience obtained an export license from the Korean Ministry of Food and Drug Safety for SK's typhoid vaccine 'SKYTyphoid' which they jointly developed.

12 May 2022

Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

A new study analyzed the imprinted antibody responses towards the SARS-CoV-2 Omicron subvariants.

12 May 2022

Study shows reduced respiratory syncytial virus antibody levels in women of childbearing age and infants during the COVID-19 pandemic

A study demonstrated that the humoral immunity against the respiratory syncytial virus (RSV) has significantly reduced.

12 May 2022

Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

Researchers extensively investigated the dynamics of antibodies induced by natural SARS-CoV-2 infection and vaccination in Qatar's diverse population

12 May 2022

CMR Surgical; Transforming Surgery through Robotics

In this interview, we speak to Mark Slack, Chief Medical Officer at CMR Surgical, about their next-generation surgical robot Versius.

From CMR Surgical 12 May 2022

CDC study of pregnant women hospitalized with COVID in 2021 found 93% not vaccinated

In a recent study posted to the Research Square* preprint server, researchers assessed the characteristics and treatment of coronavirus disease 2019 (COVID-19) in pregnant women.

12 May 2022

Research looks at potential of pantethine against SARS-CoV-2

In a recent study posted to the Research Square preprint server, researchers assessed the antiviral activity of pantethine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

12 May 2022

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

In a recent study posted to the medRxiv* preprint server, researchers estimated the efficacy of two-dose and three-dose regimens of two messenger ribonucleic acid (mRNA) vaccines: Moderna’s mRNA-1273 and Pfizer-BioNTech’s BNT162b2 against coronavirus disease 2019 (COVID-19) caused due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

12 May 2022

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

In a recent study published in the journal Vaccines, researchers revealed how severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron evades neutralizing antibodies (nAbs).

12 May 2022

Study shows link between abnormal blood clotting and impaired exercise capacity in people with long COVID

According to a study published today in Blood Advances, people suffering from long COVID may face an increased risk of abnormal blood clotting.

11 May 2022

The promise of RNA medicine is targeted and personalized

The development of messenger RNA (mRNA) vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has only increased the impetus in this field.

11 May 2022

MRC/UVRI and LSHTM Uganda Research Unit launches new state-of-the-art clinical research facility

The MRC/UVRI and LSHTM Uganda Research Unit has unveiled a new state-of-the-art clinical research facility in Entebbe to further boost its contributions to science, policy and practice in Uganda.

11 May 2022

Quality of drug supply declined in Vancouver during the COVID-19 pandemic, study finds

More than a third of people who use drugs in Vancouver, Canada reported a decline in the quality of drugs during the COVID-19 pandemic, according to a new study published in the journal Drug and Alcohol Dependence.

11 May 2022

Misperception of group concerns undermines cooperation and trust

Misperceptions of marginalized and disadvantaged communities' level of concern regarding COVID-19, as well as other issues such as climate change, constitutes a form of social misinformation that may undermine cooperation and trust needed to address collective problems, according to new Cornell-led research.

11 May 2022

Discovery of host co-factors necessary for SARS-CoV2 infection

A new study published in the journal EMBO Reports has reported on the shedding of two proteases, namely, ADAM10 and ADAM17, which aids in S protein-dependent molecular events.

11 May 2022

UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

Researchers at the University of Maryland School of Medicine (UMSOM) have been collaborating on an extensive heart registry that includes student-athletes in the Big Ten athletic conference, to learn more about cardiac issues in those who have recovered from a COVID-19 infection.

11 May 2022

COVID-19 patients with persistent viral shedding may warrant closer surveillance and monitoring for complications

A new Northwestern Medicine study published in GeroScience sought to determine the prevalence, risk factors and significance of persistent viral shedding in hospitalized COVID-19 patients.

11 May 2022

First oral antiviral approved for early treatment of COVID-19

The United States Food and Drug Administration granted an Emergency Use Authorization in December 2021 for the first oral antiviral, a pill containing two protease inhibitors – nirmatrelvir and ritonavir (Paxlovid, Pfizer) – for early treatment of COVID-19.

11 May 2022

covid 19 News and Research

Evaluating mental health of adults with neurodevelopmental disorders during COVID-19 pandemic

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

Study shows reduced respiratory syncytial virus antibody levels in women of childbearing age and infants during the COVID-19 pandemic

Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

CMR Surgical; Transforming Surgery through Robotics

CDC study of pregnant women hospitalized with COVID in 2021 found 93% not vaccinated

Research looks at potential of pantethine against SARS-CoV-2

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

Study shows link between abnormal blood clotting and impaired exercise capacity in people with long COVID

The promise of RNA medicine is targeted and personalized

MRC/UVRI and LSHTM Uganda Research Unit launches new state-of-the-art clinical research facility

Quality of drug supply declined in Vancouver during the COVID-19 pandemic, study finds

Misperception of group concerns undermines cooperation and trust

Discovery of host co-factors necessary for SARS-CoV2 infection

UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

COVID-19 patients with persistent viral shedding may warrant closer surveillance and monitoring for complications

First oral antiviral approved for early treatment of COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News